Goldman Sachs Maintains Neutral on Dentsply Sirona, Lowers Price Target to $30
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs analyst Nathan Rich maintains a Neutral rating on Dentsply Sirona (XRAY) and lowers the price target from $34 to $30.
May 06, 2024 | 3:35 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Goldman Sachs maintains a Neutral rating on Dentsply Sirona and lowers the price target from $34 to $30.
The reduction in price target by Goldman Sachs suggests a bearish outlook on the stock's short-term price potential, likely leading to negative investor sentiment and a potential decrease in stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100